The CDC estimates of the US population indicate that only 40% of adults at risk for developing diabetes are obese1. If you are one of the 60% that is not obese, how do you know your risk?
We can now move beyond BMI and look deep into one's individual chemistry. The PreD Guide assists clinicians in identifying patients at risk for developing diabetes. By integrating traditional blood sugar test with state-of-the-art inflammatory and metabolic tests, the PreD Guide pinpoints a patient’s place within the progression to diabetes.
The interplay of these tests is illustrated across the stages of pre-diabetes, and results in stage-specific treatment plan. In addition, an array of inflammatory tests are measured and aggregated to give the Average Inflammation Score (AIS). Long term Inflammation has been called the "silent killer" because the damaging effects are rarely at all felt.
This test is not only beneficial for those with pre-diabetes or diabetes. Many other health conditions are attributed to abnormal blood sugar levels and inflammation including:
The PreD Guide gives clinicians the ability to evaluate stages of pre-diabetes, determine the impact of inflammation, and individualize treatment. This clinical tool ensures, as the CDC notes, that “progression to diabetes among those with pre-diabetes is not inevitable".
What's being tested:
1. NHANES 1999-2004 & CDC BRFSS 2009